#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15216	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1964	768.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1672	1672	T	849	T,C	767,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15216	16S	1529	1529	99.93	16S.l6.c4.ctg.1	1964	768.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	915	C,A	846,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3488	793.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1632	1632	A	978	A	896	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3488	793.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2266	2266	C	937	C	840	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3488	793.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2340	2340	A	916	A	838	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27732	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3488	793.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2892	2892	C	852	C	786	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	10	blaTEM	861	115	100.0	blaTEM.l15.c4.ctg.1	115	3.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2060	folP	855	855	100.0	folP.l15.c4.ctg.1	1418	144.5	1	SNP	p	R229S	1	.	.	685	687	AGC	955	957	AGC	196;197;196	A;G;C	182;183;178	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5992	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3494	171.2	1	SNP	p	S91F	1	.	.	271	273	TTC	710	712	TTC	193;192;190	T;T;C	173;173;170	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5992	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3494	171.2	1	SNP	p	D95G	1	.	.	283	285	GGC	722	724	GGC	191;192;192	G;G,C;C	169;168,1;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5992	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3494	171.2	1	SNP	p	G95N	0	.	.	283	285	GGC	722	724	GGC	191;192;192	G;G,C;C	169;168,1;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1790	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1321	135.1	1	SNP	p	G45D	0	.	.	133	135	GGC	441	443	GGC	227;230;231	G;G,A;C	211;212,1;211	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	900	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1031	86.9	0	.	n	.	0	A197.	DEL	197	197	A	605	605	A	215	A	196	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1460	1462	GTC	191;191;189	G;T;C	173;170;173	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	1	SNP	p	D86N	0	.	.	256	258	GAC	566	568	GAC	200;201;202	G,T;A;C	183,1;185;187	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	1	SNP	p	S87R	1	.	.	259	261	CGT	569	571	CGT	203;204;207	C;G;T	187;187;188	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	1	SNP	p	R87W	0	.	.	259	261	CGT	569	571	CGT	203;204;207	C;G;T	187;187;188	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	1	SNP	p	R87I	0	.	.	259	261	CGT	569	571	CGT	203;204;207	C;G;T	187;187;188	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5322	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2960	179.1	1	SNP	p	S88P	0	.	.	262	264	TCC	572	574	TCC	207;207;209	T;C;C,G	191;191;191,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4892	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2425	200.2	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1243	1245	TGC	218;217;217	T;G,T;C	197;197,1;198	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4892	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2425	200.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1453	1455	GGC	243;244;241	G;G;C	226;226;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1320	1322	GCA	231;231;230	G;C;A	211;211;215	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1323	1325	ATC	231;229;231	A;T;C	214;214;216	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1335	1337	GTG	240;240;240	G;T;G	220;218;217	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1335	1337	GTG	240;240;240	G;T;G	220;218;217	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1839	1841	ACC	235;236;234	A;C;C	218;218;215	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1893	1895	GCG	227;225;224	G;C,T;G	194;172,1;182	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1893	1895	GCG	227;225;224	G;C,T;G	194;172,1;182	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2016	2018	GGC	213;212;211	G;G,A;C	192;190,1;192	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2025	2027	GGC	205;204;202	G;G;C	185;185;180	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4300	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2431	176.5	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2043	2045	TCG	215;213;212	T,G;C;G	137,9;167;169	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6062	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3023	199.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1660	1662	CCG	235;231;231	C;C;G,A	202;209;205,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2574	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1800	142.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	561	561	C	175	C	160	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	377	379	GAA	256;255;252	G,A;A;A	232,1;231;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	665	667	GAT	231;231;234	G;A;T	215;215;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	788	790	TCA	247;253;255	T;C;A	225;231;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	F215S	NONSYN	643	645	TTT	908	910	TCT	233;231;229	T;C,A,T;T	217;215,1,1;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	917	919	GTC	225;225;229	G,A;T;C,T	211,1;212;218,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1247	1249	GCA	242;237;235	G;C;A	220;216;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	1	SNP	p	G120K	1	.	.	358	360	AAG	623	625	AAG	238;235;237	A;A;G	223;222;225	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	1	SNP	p	D121N	0	.	.	361	363	GAC	626	628	GAC	237;236;236	G;A;C	225;222;224	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2920	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1441	201.2	1	SNP	p	A121D	1	.	.	361	363	GAC	626	628	GAC	237;236;236	G;A;C	225;222;224	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10824	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4842	223.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1970	1972	AAT	230;230;231	A;A,T;T	211;211,1;211	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1006	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1013	99.0	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	227;231;235	A;T;G	205;208;209	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	528	4	tetM	1920	183	99.45	tetM.l15.c4.ctg.1	183	2.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	81	83	GAA	3;3;3	G;A;A	2;2;2	.	Tetracycline resistance
